Advance in identified targets of berberine
Berberine is an isoquinoline alkaloid, which has demonstrated significant therapeutic potential in the treatment of various diseases, including tumors, acute and chronic infections, autoimmune disorders, and diabetes. Studies have demonstrated that berberine exhibits polypharmacological effects, inc...
Saved in:
Main Authors: | Penghai Sun, Ziyuan Wang, Yinchao Ma, Yuan Liu, Yintong Xue, Yan Li, Xiang Gao, Yuedan Wang, Ming Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1500511/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Predicted Helix-Turn-Helix Core Is Critical for Bacteriophage Kil Peptide to Disrupt <i>Escherichia coli</i> Cell Division
by: Arindam Naha, et al.
Published: (2025-01-01) -
Differential GTP-dependent in-vitro polymerization of recombinant Physcomitrella FtsZ proteins
by: Stella W. L. Milferstaedt, et al.
Published: (2025-01-01) -
Dual role of ramR mutation in enhancing immune activation and elevating eravacycline resistance in Klebsiella pneumoniae
by: Wei Yu, et al.
Published: (2024-12-01) -
Elucidation of the mechanism of berberine against gastric mucosa injury in a rat model with chronic atrophic gastritis based on a combined strategy of multi-omics and molecular biology
by: Lisheng Chen, et al.
Published: (2025-01-01) -
Rare coexistence of spinal muscular atrophy with membranous nephropathy – A clinical conundrum with management dilemma
by: Gerry G. Mathew, et al.
Published: (2024-12-01)